KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Boston Scientific (BSX) Preferred Dividend Payments (2020 - 2023)

Boston Scientific's Preferred Dividend Payments history spans 4 years, with the latest figure at $9.0 million for Q2 2023.

  • On a quarterly basis, Preferred Dividend Payments fell 35.71% to $9.0 million in Q2 2023 year-over-year; TTM through Mar 2024 was $9.0 million, a 83.64% decrease, with the full-year FY2023 number at $23.0 million, down 58.18% from a year prior.
  • Preferred Dividend Payments hit $9.0 million in Q2 2023 for Boston Scientific, down from $14.0 million in the prior quarter.
  • Over the last five years, Preferred Dividend Payments for BSX hit a ceiling of $14.0 million in Q3 2020 and a floor of $5.0 million in Q2 2020.
  • Historically, Preferred Dividend Payments has averaged $12.8 million across 4 years, with a median of $14.0 million in 2020.
  • Biggest five-year swings in Preferred Dividend Payments: skyrocketed 180.0% in 2021 and later plummeted 35.71% in 2023.
  • Tracing BSX's Preferred Dividend Payments over 4 years: stood at $14.0 million in 2020, then fell by 7.14% to $13.0 million in 2021, then changed by 0.0% to $13.0 million in 2022, then crashed by 30.77% to $9.0 million in 2023.
  • Business Quant data shows Preferred Dividend Payments for BSX at $9.0 million in Q2 2023, $14.0 million in Q1 2023, and $13.0 million in Q4 2022.